Atorvastatin Epoxy Tetrahydrofuran IMpurity
|
|
|
- CAS-Nr.
- 873950-19-7
- Englisch Name:
- Atorvastatin Epoxy Tetrahydrofuran IMpurity
- Synonyma:
- Atorvastatin 2;Atorvastatin-FXA2;Atorvastatin Impurity 22;Atorvastatin Impurity 5 CRS;Atorvastatin epoxy THF analog;4-(4-fluorophenyl)-2,4-dihydroxy;Atorvastatin epoxy dihydroxy imp;Atorvastatin calcium impurity 14;Atorvastatin epoxy tetrahydrofuran;Atorvastatin Dihydroxy Epoxy Impurity
- CBNumber:
- CB42543602
- Summenformel:
- C26H24FNO5
- Molgewicht:
- 449.47
- MOL-Datei:
- 873950-19-7.mol
|
Atorvastatin Epoxy Tetrahydrofuran IMpurity Eigenschaften
- Schmelzpunkt:
- >163°C (dec.)
- Siedepunkt:
- 661.1±55.0 °C(Predicted)
- Dichte
- 1.435±0.06 g/cm3(Predicted)
- storage temp.
- -20°C Freezer, Under inert atmosphere
- L?slichkeit
- Chloroform (Slightly), DMSO
- Aggregatzustand
- Solid
- pka
- 10.43±0.70(Predicted)
- Farbe
- White to Off-White
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| Bildanzeige (GHS) |
|
| Alarmwort |
Warnung |
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H319 |
Verursacht schwere Augenreizung. |
Schwere Augenreizung |
Kategorie 2 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P305+P351+P338,P337+P313P |
|
| Sicherheit |
| P264 |
Nach Gebrauch gründlich waschen. |
| P264 |
Nach Gebrauch gründlich waschen. |
| P280 |
Schutzhandschuhe/Schutzkleidung/Augenschutz tragen. |
| P305+P351+P338 |
BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen. |
|
Atorvastatin Epoxy Tetrahydrofuran IMpurity Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
White Solid
Verwenden
Atorvastatin (A791750) impurity.
Atorvastatin Epoxy Tetrahydrofuran IMpurity Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Atorvastatin Epoxy Tetrahydrofuran IMpurity Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 87)Lieferanten
873950-19-7()Verwandte Suche:
- Atorvastatin Epoxy Tetrahydrofuran IMpurity
- 4-(4-Fluorophenyl)-2,4-dihydroxy-2-(1-Methylethyl)-N,5-diphenyl-3,6-dioxabicyclo[3.1.0]hexane-1-carboxaMide
- Atorvastatin Photo Degradation Product
- Atorvastatin Epoxy Tetrahydrofuran Analog
- Atorvastatin 2
- Atorvastatin epoxy THF analog
- 4-(4-fluorophenyl)-2,4-dihydroxy-N,5-diphenyl-2-propan-2-yl-3,6-dioxabicyclo[3.1.0]hexane-1-carboxamide
- Atorvastatin Epoxy Tetrahydrofuraran analog
- 4-(4-fluorophenyl)-2,4-dihydroxy
- Atorvastatin impurity 28/Atorvastatin Epoxy Tetrahydrofuran Impurity/4-(4-Fluorophenyl)-2,4-dihydroxy-2-(1-methylethyl)-N,5-diphenyl-3,6-dioxabicyclo[3.1.0]hexane-1-carboxamide
- Atorvastatin epoxy tetrahydrofuran
- 4-(4-Fluorophenyl)-2,4-dihydroxy-2-isopropyl-N,5-diphenyl-3,6-dioxabicyclo [3.1.0]hexane-1-carboxamide
- Atorvastatin-FXA2
- Atorvastatin Degradation Product - FXA2
- 3,6-Dioxabicyclo[3.1.0]hexane-1-carboxamide, 4-(4-fluorophenyl)-2,4-dihydroxy-2-(1-methylethyl)-N,5-diphenyl-
- Atorvastatin Dihydroxy Epoxy Impurity
- Atorvastatin epoxy tetrahydrofuran analogue
- Atorvastatin calcium impurity epoxy tetrahydrofuran
- Atorvastatin Epoxy Tetrahydrofuran Analog (Atorvastatin Dihydroxy Epoxy Impurity/ Atorvastatin Degradation Product - FXA2)
- Atorvastatin Epoxy Tetrahydrofuran AnalogQ: What is
Atorvastatin Epoxy Tetrahydrofuran Analog Q: What is the CAS Number of
Atorvastatin Epoxy Tetrahydrofuran Analog Q: What is the storage condition of
Atorvastatin Epoxy Tetrahydrofuran Analog Q: What are the applications of
Atorvastatin Epoxy Tetrahydrofuran Analog
- Atorvastatin epoxy dihydroxy imp
- ATORVASTATIN EPOXY TETRAHYDROFURAN ALOG
- Atorvastatin calcium impurity 14
- Atorvastatin Epoxy Tetrahydrofuraran Analog（Atorvastatin Impurity 9）
- Atorvastatin Impurity 5 CRS
- Atorvastatin Impurity 22
- Atorvastatin epoxy tetrahydrofuran analog impurity
- 873950-19-7
- Amines
- Aromatics
- Chiral Reagents
- Impurities
- Intermediates & Fine Chemicals
- Pharmaceuticals
